171 related articles for article (PubMed ID: 36038420)
21. Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications.
Zhai X; Lin Y; Zhu L; Wang Y; Zhang J; Liu J; Li L; Lu X
Cytokine Growth Factor Rev; 2024 Feb; 75():101-109. PubMed ID: 37658030
[TBL] [Abstract][Full Text] [Related]
22. Anti-PD-L1 DNAzyme Loaded Photothermal Mn
Liu P; Shi X; Peng Y; Hu J; Ding J; Zhou W
Adv Healthc Mater; 2022 Apr; 11(8):e2102315. PubMed ID: 34841741
[TBL] [Abstract][Full Text] [Related]
23. Boosting cancer immunotherapy by biomineralized nanovaccine with ferroptosis-inducing and photothermal properties.
Ma S; Liang X; Yang N; Yang J; Zhang J; Pan X; Wei Y; Liu Z; Shen Q
Biomater Sci; 2023 Jan; 11(2):518-532. PubMed ID: 36468623
[TBL] [Abstract][Full Text] [Related]
24. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
Gu X; Liu Y; Dai X; Yang YG; Zhang X
Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
[TBL] [Abstract][Full Text] [Related]
25. Ferroptosis and Cancer Immunotherapy.
Yin J; Meng X; Peng L; Xie W; Liu X; He W; Li S
Curr Mol Med; 2023; 23(5):401-409. PubMed ID: 35579155
[TBL] [Abstract][Full Text] [Related]
26. Ferroptosis-Enhanced Cancer Immunity by a Ferrocene-Appended Iridium(III) Diphosphine Complex.
Wang WJ; Ling YY; Zhong YM; Li ZY; Tan CP; Mao ZW
Angew Chem Int Ed Engl; 2022 Apr; 61(16):e202115247. PubMed ID: 34965011
[TBL] [Abstract][Full Text] [Related]
27. Zinc-Iron Bimetallic Peroxides Modulate the Tumor Stromal Microenvironment and Enhance Cell Immunogenicity for Enhanced Breast Cancer Immunotherapy Therapy.
Lu Y; Chen Y; Hou G; Lei H; Liu L; Huang X; Sun S; Liu L; Liu X; Na J; Zhao Y; Cheng L; Zhong L
ACS Nano; 2024 Apr; 18(15):10542-10556. PubMed ID: 38561324
[TBL] [Abstract][Full Text] [Related]
28. Immunogenic ferroptosis and where to find it?
Demuynck R; Efimova I; Naessens F; Krysko DV
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903554
[TBL] [Abstract][Full Text] [Related]
29. Topology regulation of nanomedicine for autophagy-augmented ferroptosis and cancer immunotherapy.
Hu R; Dai C; Dai X; Dong C; Huang H; Song X; Feng W; Ding L; Chen Y; Zhang B
Sci Bull (Beijing); 2023 Jan; 68(1):77-94. PubMed ID: 36621435
[TBL] [Abstract][Full Text] [Related]
30. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis and its interaction with tumor immune microenvironment in liver cancer.
Huang Y; Wang S; Ke A; Guo K
Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188848. PubMed ID: 36502929
[TBL] [Abstract][Full Text] [Related]
32. Iron based nanotherapeutics for ferroptosis-induced cancer therapy.
Liu YM; Chen YH; Jin YC; Tang KZ
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11323-11333. PubMed ID: 33215452
[TBL] [Abstract][Full Text] [Related]
33. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
[TBL] [Abstract][Full Text] [Related]
34. Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.
Chin YC; Yang LX; Hsu FT; Hsu CW; Chang TW; Chen HY; Chen LY; Chia ZC; Hung CH; Su WC; Chiu YC; Huang CC; Liao MY
J Nanobiotechnology; 2022 Aug; 20(1):373. PubMed ID: 35953837
[TBL] [Abstract][Full Text] [Related]
35. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H
Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581
[TBL] [Abstract][Full Text] [Related]
36. Self-assembled nano-activator constructed ferroptosis-immunotherapy through hijacking endogenous iron to intracellular positive feedback loop.
Xiong H; Wang C; Wang Z; Lu H; Yao J
J Control Release; 2021 Apr; 332():539-552. PubMed ID: 33689796
[TBL] [Abstract][Full Text] [Related]
37. Disruption of dual homeostasis by a metal-organic framework nanoreactor for ferroptosis-based immunotherapy of tumor.
Zhang K; Ma Z; Li S; Wu Y; Zhang J; Zhang W; Zhao Y; Han H
Biomaterials; 2022 May; 284():121502. PubMed ID: 35390708
[TBL] [Abstract][Full Text] [Related]
38. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
39. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions.
Lei G; Zhuang L; Gan B
Cancer Cell; 2024 Apr; 42(4):513-534. PubMed ID: 38593779
[TBL] [Abstract][Full Text] [Related]
40. Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors.
Cai H; Ren Y; Chen S; Wang Y; Chu L
Front Oncol; 2023; 13():1119369. PubMed ID: 36845720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
